Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence.

@article{Hoensch2008ProspectiveCC,
  title={Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence.},
  author={Harald Peter Hoensch and Bertram Groh and Lutz Edler and Wilhelm Kirch},
  journal={World journal of gastroenterology},
  year={2008},
  volume={14 14},
  pages={2187-93}
}
AIM To investigate biological prevention with flavonoids the recurrence risk of neoplasia was studied in patients with resected colorectal cancer and after adenoma polypectomy. METHODS Eighty-seven patients, 36 patients with resected colon cancer and 51 patients after polypectomy, were divided into 2 groups: one group was treated with a flavonoid mixture (daily standard dose 20 mg apigenin and 20 mg epigallocathechin-gallat, n = 31) and compared with a matched control group (n = 56). Both… CONTINUE READING